Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines

Drug Testing and Analysis

Volumn 4, Issue 1, 2012, Pages 24-32

  Brandt, Simon D ^a   Tearavarich, Ruchanok ^b   Dempster, Nicola ^a   Cozzi, Nicholas V ^c   Daley, Paul F ^d  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b RAJAMANGALA UNIVERSITY OF TECHNOLOGY ISAN   (Thailand)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Lafayette Pediatrics   (United States)

Author keywords

Mass spectrometry; Microwave; Nuclear magnetic resonance; Psychoactive; Receptor probes; Tryptamines

Indexed keywords

FORENSIC SCIENCE; GAS CHROMATOGRAPHY; IONIZATION OF GASES; IONS; ISOMERS; MASS SPECTROMETRY; TOXICITY;

CLINICAL ANALYSIS; EMERGING SUBSTANCES; FORENSIC ANALYSIS; METHOXY; PROPERTY; PSYCHOACTIVE; RECEPTOR PROBES; REFERENCE MATERIAL; SYNTHESIS AND CHARACTERIZATIONS; TRYPTAMINES;

NUCLEAR MAGNETIC RESONANCE;

2 ETHYL 5 METHOXY 3 [(1 METHYLPYRROLIDIN 2 YL)METHYL] 1,H INDOLE; 5 METHOXY 2 ETHYL N,N DIMETHYLTRYPTAMINE; 5 METHOXY 2 METHYL N,N DIMETHYLTRYPTAMINE; 5 METHOXY 2 METHYLINDOL 3 YL N ALLYL N CYCLOHEXYL GLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ALLYL N METHYL GLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ETHYL N (2 METHYLALLYL)GLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ETHYL N ISOPROPYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ETHYL N METHYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ETHYL N PROPYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N ISOPROPYL N METHYL GLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N METHYL N PROPYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N,N DIALLYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N,N DIETHYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N,N DIISOPROPYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N,N DIMETHYLGLYOXALYLAMIDE; 5 METHOXY 2 METHYLINDOL 3 YL N,N DIPROPYLGLYOXALYLAMIDE; 5 METHOXY 2 PHENYL N,N DIMETHYLTRYPTAMINE; 5 METHOXY N,N DIMETHYLTRYPTAMINE; N,N DIMETHYLTRYPTAMINE; PSYCHOTROPIC AGENT; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL IONIZATION ION TRAP TANDEM MASS SPECTROMETRY; DRUG DESIGN; DRUG DETERMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON IONIZATION ION TRAP MASS SPECTROMETRY; GAS CHROMATOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TANDEM MASS SPECTROMETRY;

EID: 84856387591     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.398     Document Type: Article

References (28)

1. 6 serotonin receptors. J. Med. Chem. 2000, 43, 1011.
2. 6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Discov. Today 2006, 11, 283.
3. 6 receptor ligands with a focus on arylsulfonyltryptamine analogs. Curr. Top. Med. Chem. 2010, 10, 579.
4. A. V. Ivachtchenko, Y. A. Ivanenkov, S. E. Tkachenko 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey. Expert Opin. Ther. Patents 2010, 20, 1171.
5. 6 serotonin receptors: Receptor modeling studies. J. Med. Chem. 2008, 51, 603.
6. 6 receptors. Bioorg. Med. Chem. Lett. 2006, 16, 5832.
7. A. T. Shulgin, A. Shulgin TIHKAL: The Continuation, Transform Press, Berkeley, CA, USA, 1997.
8. J. Ott Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N, N-dimethyl-tryptamine. J. Psychoactive Drugs 2001, 33, 403.
9. A. T. Shulgin Basic pharmacology and effects. In Hallucinogens. A Forensic Drug Handbook, Chapter 3, (Ed: R.R. Laing ). Elsevier Science Ltd, London, 2003, pp. 67.
10. D. E. Nichols Hallucinogens. Pharmacol. Ther. 2004, 101, 131.
11. N. V. Cozzi, A. Gopalakrishnan, L. L. Anderson, J. T. Feih, A. T. Shulgin, P. F. Daley, A. E. Ruoho Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J. Neural Transm. 2009, 116, 1591.
12. D. Fontanilla, M. Johannessen, A. R. Hajipour, N. V. Cozzi, M. B. Jackson, A. E. Ruoho The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009, 323, 934.
13. T. S. Ray Psychedelics and the human receptorome. PLoS One 2010, 5, e9019.
14. B. Sanders, S. E. Lankenau, J. J. Bloom, D. Hathazi 'Research chemicals': tryptamine and phenethylamine use among high-risk youth. Subst. Use Misuse 2008, 43, 389.
15. L. A. King Forensic Chemistry of Substance Misuse. A Guide to Drug Control. The Royal Society of Chemistry, Cambridge, UK, 2009.
16. H. R. Sumnall, M. Evans-Brown, J. McVeigh Social, policy, and public health perspectives on new psychoactive substances. Drug Test. Analysis 2011, 3, 515.
17. 4]-tryptamines. Drug Test. Analysis 2011, 3, 597.
18. 4]-tryptamines. J. Label. Compd. Radiopharm. 2008, 51, 423.
19. M. E. Speeter, W. C. Anthony The action of oxalyl chloride on indoles: a new approach to tryptamines. J. Am. Chem. Soc. 1954, 76, 6208.
20. E. Shaw The synthesis of tryptamines related to serotonin. J. Am. Chem. Soc. 1955, 77, 4319.
21. 6 selective ligands. GB 2341549 A 2000.
22. 6 receptor ligands. J. Med. Chem. 2001, 44, 3881.
23. V. S. N. Ramkrishna, R. S. Kambhampati, V. S. Shirsath, V. Jasti Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones. WO 2004/041781 A1 2004.
24. C. Kuehm-Caubère, I. Rodriguez, B. Pfeiffer, P. Renard, P. Caubère Efficient selective synthesis of 2-substituted indoles from complex-base-promoted arynic cyclisations. J. Chem. Soc. Perkin Trans. 1 1997, 2857.
25. C. Sârbu, N. R dulescu, M. Ionescu, S. Negriţescu, C. Ioan, N. Boeşteanu, M. Simionovici New indole derivatives with biological activity. Rev. Roum. Chim. 1980, 25, 245.
26. B. L. Zenitz 3-(Piperidino-lower-alkyl)indoles. US Patent No. 4021431 A 1977.
27. S. D. Brandt, S. Freeman, I. A. Fleet, P. McGagh, J. F. Alder Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N, N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR. Analyst 2005, 130, 330.
28. D. Mansell, S. Brandt, S. Nasima, N. Turvey, J. Alder, S. Freeman, C. Schwalbe Conformational evaluation of indol-3-yl-N-alkyl-glyoxalylamides and indol-3-yl-N, N-dialkyl-glyoxalylamides. Spectrosc. Lett. 2009, 42, 156.